author-photo

Bingming Yi

Merck & Co.

9

Papers

1465

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.

2011 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (29)
Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects.

2006 CP | Principles and Practice of Constraint Programming
Show All
- Source
- Cite
- Save
Citations (16)
PIII-64Multiple dose administration of MK-0431 (sitagliptin), an inhibitor of dipeptidyl peptidase-IV, does not meaningfully alter the plasma pharmacokinetics or pharmacodynamics of single doses of warfarin

2006 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (16)
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

2006 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (243)
Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

2006 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (449)
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.

2005 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (443)